Medical Action Industries Inc.
CardioInsight chief Arless replaced by 2-man “office of the president” | Personnel Moves
Boston Scientific launches Pluromed’s BackStop kidney stone treatment | Wall Street Beat
Boston Scientific (NYSE:BSX) launched its BackStop kidney stone treatment product in the U.S. and certain international markets this week.
Ex-J&J CEO Weldon to walk with $143.5M in retirement | Personnel Moves
Outgoing Johnson & Johnson (NYSE:JNJ) CEO William Weldon will take home $143.5 million in retirement benefits when he walks in April.
The veteran J&J employee racked up more than $95 million in deferred compensation and $48.4 million in pension benefits over more than 40 years with the health care titan, according to an SEC filing.
Bard’s Q4 results give it a bump | Earnings Roundup
Investors on Wall Street shrugged off the $51 million hit to C.R. Bard’s (NYSE:BCR) bottom line from a legal settlement, bumping shares up about 2% today.
BD slides on missed Q4 expectations, 24% profit decline | Earnings Roundup
Shares of Becton Dickinson (NYSE:BDX) slipped 4.4 percent today after the company announced a 24.4 percent profit slide and missed Wall Street’s expectations for its Q4 earnings.
BD posted profits of $300.0 million, or $1.36 per share, on sales of $2.05 billion for the three months ended Sept. 30. That compares with profits of $396.7 million, or $1.68 per share, on sales of $1.87 billion during the same period last year.
Uroplasty beats Wall Street, closes near all-time high | Earnings Roundup
Uroplasty Inc. (NSDQ:UPI) beat Wall Street and closed near its all-time high after reporting strong top-line growth for the fourth quarter and full year today.
Earnings roundup: Vascular Solutions profits rocket 838 percent
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Bottom line surges 254 percent for Medical Action Industries
Medical Action Industries Inc. (NSDQ:MDCI) posted third-quarter sales of $73.2 million for the three months ended Dec. 31, 2009, up 1.6 percent compared with $72 million during the same period in 2008. Net income surged 245 percent to $4 million, compared with $157,000 during Q3 2009:
Press Release
Medical Action Industries Reports Strong Third Quarter 2010 Fiscal Results
Company Reports Gains in Net Income and Gross Profit; Increase in Cash Flow Facilitates a $9.7 Million Debt Reduction in the Third Quarter and a $30.7 Million Debt Reduction Year to Date